首页 > 最新文献

OTORHINOLARYNGOLOGY No3(4) 2021最新文献

英文 中文
Ways to increase compliance in patients with acute otitis externa 提高急性外耳炎患者依从性的方法
Pub Date : 2021-06-14 DOI: 10.37219/2528-8253-2021-3-71
O. Semenyuk, Oksana Moskalyk
Topicality: The problem of diagnosis and treatment of otitis externa (OE) has been posed to doctors for a long time, and until the discovery of antibiotics (AB) and antifungal drugs (AFD) remained unresolved. OE can affect up to 10% of people at different periods of their lives, manifesting itself in the form of acute OE (AOE) in 95% of cases after the age of 2 years. There is a reduction in the number of patients admittance to the ENT specialist with the onset of the COVID-19 pandemic while maintaining the structure of the pathology, where AOE - in the top three of frequency. At the same time, there are a reports of an increasing amount of AOE cases in patients with COVID-19.Aim: To evaluate the dynamics of pain, the need for additional analgesia, systemic antibacterial therapy (ABT) or topical antifungal therapy (TAT), the level of compliance in patients with AOE in empirical treatment with a complex drug «Candibiotic» in comparison with protocol treatment.Material and methods: The study included adults and children from 2 years of age with a diagnosis of AOE: 30 patients in the main (17 adults, 13 children) and 25 patients in the control (15 adults, 10 children) groups. Patients in the main group as a basic treatment received topical ear drops «Candibiotic». Patients in the control group received protocol treatment. If necessary, patients were additionally prescribed analgesic therapy (ibuprofen in the appropriate dose), systemic ABT or TAT. For subjective pain asses, a visual analog scale (VAS) was used. Compliance was assessed using the Morisky-Green questionnaire. The obtained results were processed by common statistical methods.Results and discussion: In the main group of patients receiving «Candibiotic», there were fewer needs for additional systemic analgesia, systemic ABT, no one needed additional TAT. Comparison of the obtained results (percentage) in the form of arbitrary tables using the chi-squared test established that the relationship between factor and performance traits is not statistically significant (p>0.05). The mean compliance score between the two study groups differed significantly as a whole and separately between the groups of adults and children (p<0.05).Conclusion: In patients of adult and pediatric age with a diagnosis of AOE at the initial empirical appointment of the drug «Candibiotic» there was less need for additional analgesia, the appointment of systemic ABT and AFT. Such results did not differ statistically significantly from the results in adult and pediatric patients who were prescribed protocol treatment of AOE. Patients with «Candibiotic» monotherapy had a significantly higher average compliance score compared with the control group, especially among parents of children with AOE. The complex composition of ear drops «Candibiotic» contributes to a high adherence to treatment in patients, and the lack of an absolute analogue makes it the means of choice for the initial empirical treatment of AOE in adult
外耳炎(OE)的诊断和治疗问题一直困扰着医生,直到抗生素(AB)和抗真菌药物(AFD)的发现才得到解决。OE可影响高达10%的人在其生命的不同时期,在95%的2岁以后的病例中表现为急性OE (AOE)。随着COVID-19大流行的发生,耳鼻喉科专科的患者入院人数减少,同时保持病理结构,其中AOE -在频率上排名前三。与此同时,有报道称,COVID-19患者的AOE病例越来越多。目的:评估疼痛的动态变化,是否需要额外的镇痛、全身抗菌治疗(ABT)或局部抗真菌治疗(TAT),以及AOE患者对复合药物“念珠菌”的经验治疗与方案治疗的依从性水平。材料与方法:本研究纳入诊断为AOE的2岁成人和儿童:主组30例(成人17例,儿童13例),对照组25例(成人15例,儿童10例)。主组患者作为基本治疗接受局部滴耳剂“念珠菌”。对照组患者接受方案治疗。如有必要,患者还需要额外的镇痛治疗(适当剂量的布洛芬),全身ABT或TAT。主观疼痛评分采用视觉模拟量表(VAS)。使用Morisky-Green问卷评估依从性。所得结果采用一般统计方法进行处理。结果和讨论:在接受“念珠菌”的主要患者组中,需要额外全身镇痛和全身ABT的患者较少,没有人需要额外TAT。将所得结果(百分比)以任意表的形式进行比较,采用卡方检验,各因素与生产性能性状之间的关系无统计学意义(p>0.05)。两组患者的平均依从性评分整体差异显著,成人组与儿童组的依从性评分差异显著(p<0.05)。结论:在诊断为AOE的成人和儿童年龄的患者中,在最初的经验预约药物“念菌”时,需要额外的镇痛,预约全身ABT和AFT的需求较少。这些结果与处方AOE治疗的成人和儿童患者的结果没有统计学差异。与对照组相比,接受“念珠菌”单药治疗的患者的平均依从性得分明显更高,特别是在AOE患儿的父母中。“念珠菌”滴耳液的复杂成分有助于患者对治疗的高依从性,并且缺乏绝对类似物使其成为成人和儿童2年以上AOE初始经验治疗的首选手段。
{"title":"Ways to increase compliance in patients with acute otitis externa","authors":"O. Semenyuk, Oksana Moskalyk","doi":"10.37219/2528-8253-2021-3-71","DOIUrl":"https://doi.org/10.37219/2528-8253-2021-3-71","url":null,"abstract":"Topicality: The problem of diagnosis and treatment of otitis externa (OE) has been posed to doctors for a long time, and until the discovery of antibiotics (AB) and antifungal drugs (AFD) remained unresolved. OE can affect up to 10% of people at different periods of their lives, manifesting itself in the form of acute OE (AOE) in 95% of cases after the age of 2 years. There is a reduction in the number of patients admittance to the ENT specialist with the onset of the COVID-19 pandemic while maintaining the structure of the pathology, where AOE - in the top three of frequency. At the same time, there are a reports of an increasing amount of AOE cases in patients with COVID-19.\u0000Aim: To evaluate the dynamics of pain, the need for additional analgesia, systemic antibacterial therapy (ABT) or topical antifungal therapy (TAT), the level of compliance in patients with AOE in empirical treatment with a complex drug «Candibiotic» in comparison with protocol treatment.\u0000Material and methods: The study included adults and children from 2 years of age with a diagnosis of AOE: 30 patients in the main (17 adults, 13 children) and 25 patients in the control (15 adults, 10 children) groups. Patients in the main group as a basic treatment received topical ear drops «Candibiotic». Patients in the control group received protocol treatment. If necessary, patients were additionally prescribed analgesic therapy (ibuprofen in the appropriate dose), systemic ABT or TAT. For subjective pain asses, a visual analog scale (VAS) was used. Compliance was assessed using the Morisky-Green questionnaire. The obtained results were processed by common statistical methods.\u0000Results and discussion: In the main group of patients receiving «Candibiotic», there were fewer needs for additional systemic analgesia, systemic ABT, no one needed additional TAT. Comparison of the obtained results (percentage) in the form of arbitrary tables using the chi-squared test established that the relationship between factor and performance traits is not statistically significant (p>0.05). The mean compliance score between the two study groups differed significantly as a whole and separately between the groups of adults and children (p<0.05).\u0000Conclusion: In patients of adult and pediatric age with a diagnosis of AOE at the initial empirical appointment of the drug «Candibiotic» there was less need for additional analgesia, the appointment of systemic ABT and AFT. Such results did not differ statistically significantly from the results in adult and pediatric patients who were prescribed protocol treatment of AOE. Patients with «Candibiotic» monotherapy had a significantly higher average compliance score compared with the control group, especially among parents of children with AOE. The complex composition of ear drops «Candibiotic» contributes to a high adherence to treatment in patients, and the lack of an absolute analogue makes it the means of choice for the initial empirical treatment of AOE in adult","PeriodicalId":19612,"journal":{"name":"OTORHINOLARYNGOLOGY No3(4) 2021","volume":"53 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91091651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immunodiagnostics, immunotherapy and immunoprophylaxis in otorhinolaryngological practice.Report 3. Diagnostic approaches to the palatine tonsils functional state assessment for selecting a treatment strategy for patients with chronic tonsillitis (analytical summary) 耳鼻喉科实践中的免疫诊断、免疫治疗和免疫预防。报告3。慢性扁桃体炎患者腭扁桃体功能状态评估选择治疗策略的诊断方法(分析总结)
Pub Date : 2021-06-14 DOI: 10.37219/2528-8253-2021-3-22
O. Melnikov, D. Zabolotny, A. Bredun, V. Kishchuk
Experimental work carried out over the past 20 years to study the activity of various functional groups in tonsillar cells in patients with chronic tonsillitis (CT) under local exposure to various immune response modifiers showed that:- tonsillar cells from CT patients in 69.5% of cases are capable of increasing their immunofunctional activity under the influence of immune modifiers in vitro reactions;- the most active of the group of immunotropic immune response modifiers are T-activin and Thymogen;- it can be considered the optimal diagnostic technique to carry out a "stress" test on the tonsil tissue using nonspecific (alternating magnetic field of industrial (low) frequency and low-frequency ultrasound) and specific — a microbial vaccine when applied to the tonsil tissue;- a non-invasive method for recording changes in the tonsils after stimulation may be fluctuations in the level of secretory immunoglobulin A and α-interferon in saliva after the test;- an increase in the level of secretory immunoglobulin A and α-interferon by more than 1/3 of the initial level after the test is a clinically favorable sign and a recommendation for medical treatment to the managing of patients with CT.
近20年来对慢性扁桃体炎(CT)患者局部暴露于各种免疫应答调节剂下扁桃体细胞中各种功能基团活性的实验研究表明:- 69.5%的CT患者扁桃体细胞在免疫调节剂的体外反应影响下,其免疫功能活性能够提高;-免疫性免疫应答调节剂组中活性最高的是t激活素和使用非特异性(工业(低)频率和低频超声交变磁场)和特异性-对扁桃体组织进行“应力”测试,可以被认为是最佳的诊断技术-记录刺激后扁桃体变化的无创方法可能是唾液中分泌性免疫球蛋白a和α-干扰素水平在试验后的波动;-分泌性免疫球蛋白a和α-干扰素水平在试验后的初始水平的1/3以上的增加是临床有利的迹象,是CT患者管理的医学治疗建议。
{"title":"Immunodiagnostics, immunotherapy and immunoprophylaxis in otorhinolaryngological practice.\u0000Report 3. Diagnostic approaches to the palatine tonsils functional state assessment for selecting a treatment strategy for patients with chronic tonsillitis (analytical summary)","authors":"O. Melnikov, D. Zabolotny, A. Bredun, V. Kishchuk","doi":"10.37219/2528-8253-2021-3-22","DOIUrl":"https://doi.org/10.37219/2528-8253-2021-3-22","url":null,"abstract":"Experimental work carried out over the past 20 years to study the activity of various functional groups in tonsillar cells in patients with chronic tonsillitis (CT) under local exposure to various immune response modifiers showed that:\u0000- tonsillar cells from CT patients in 69.5% of cases are capable of increasing their immunofunctional activity under the influence of immune modifiers in vitro reactions;\u0000- the most active of the group of immunotropic immune response modifiers are T-activin and Thymogen;\u0000- it can be considered the optimal diagnostic technique to carry out a \"stress\" test on the tonsil tissue using nonspecific (alternating magnetic field of industrial (low) frequency and low-frequency ultrasound) and specific — a microbial vaccine when applied to the tonsil tissue;\u0000- a non-invasive method for recording changes in the tonsils after stimulation may be fluctuations in the level of secretory immunoglobulin A and α-interferon in saliva after the test;\u0000- an increase in the level of secretory immunoglobulin A and α-interferon by more than 1/3 of the initial level after the test is a clinically favorable sign and a recommendation for medical treatment to the managing of patients with CT.","PeriodicalId":19612,"journal":{"name":"OTORHINOLARYNGOLOGY No3(4) 2021","volume":"1999 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88282185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
OTORHINOLARYNGOLOGY No3(4) 2021
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1